PRESS RELEASE published on 09/18/2024 at 18:13, 2 months 2 days ago BILENDI: Creating discussion guides for market research is now possible with AI, thanks to BARI and Bilendi Discuss Bilendi introduces AI-powered research assistant BARI for creating market research discussion guides efficiently. Givaudan uses Bilendi Discuss for automated qualitative project in five countries AI Market Research Bilendi Givaudan BARI
BRIEF published on 09/16/2024 at 18:24, 2 months 4 days ago Bilendi presents two innovative projects based on BARI AI at ESOMAR congress Artificial Intelligence Market Research Innovative Projects Bilendi Discuss ESOMAR Congress
PRESS RELEASE published on 09/16/2024 at 18:19, 2 months 4 days ago BILENDI: Bilendi unveils 2 projects based on its BARI generative artificial intelligence, presented at the ESOMAR world congress Bilendi unveils 2 innovative projects based on BARI generative artificial intelligence at ESOMAR world congress, showcasing AI in market research Artificial Intelligence Market Research Bilendi BARI ESOMAR
BRIEF published on 07/24/2024 at 18:20, 3 months 27 days ago BILENDI: H1 2024 Revenues Reach €30.6m, Up 3.6% Revenues EBITDA AI Q2 2024 Bilendi
PRESS RELEASE published on 07/24/2024 at 18:15, 3 months 27 days ago BILENDI: H1 2024 revenues: €30.6m, up +3.6% Bilendi reports €30.6m revenues for H1 2024, up +3.6%. Continued growth in France and international markets. Focus on AI-driven market research and ESG initiatives Revenues AI ESG Growth Bilendi
BRIEF published on 07/03/2024 at 09:00, 4 months 18 days ago BILENDI: Half-Year Results of the Liquidity Contract for H1 2024 Securities Liquidity Contract Transactions Bilendi Gilbert Dupont Stock Exchange Company
PRESS RELEASE published on 07/03/2024 at 08:56, 4 months 18 days ago BILAN SEMESTRIEL – S1 2024 – DU CONTRAT DE LIQUIDITE Press release of the semi-annual report S1 2024 of the liquidity contract with Gilbert Dupont Stock Exchange. Details of transactions and financial status disclosed Liquidity Contract Financial Report Gilbert Dupont Market Research Bilendi
PRESS RELEASE published on 07/03/2024 at 08:55, 4 months 18 days ago BILAN SEMESTRIEL – S1 2024 – DU CONTRAT DE LIQUIDITE Bilendi reports S1 2024 liquidity contract overview with Gilbert Dupont, highlighting transaction details and financial status Liquidity Contract Financial Report Gilbert Dupont Bilendi S1 2024
BRIEF published on 07/03/2024 at 08:51, 4 months 18 days ago Half-yearly H1 2024 review of the Bilendi Liquidity Contract Liquidity Contract Transactions Bilendi H1 2024 Gilbert Dupont Stock Exchange Company
BRIEF published on 05/14/2024 at 17:39, 6 months 6 days ago BILENDI Posts Q1 2024 Revenue Growth, Boosted by AI Innovations Artificial Intelligence Corporate Strategy Q1 2024 Growth Bilendi Revenue Increase BARI Technology
Published on 11/21/2024 at 14:00, 20 minutes ago Demotech, Inc. Assigns a Financial Stability Rating(R) of A, Exceptional, to Steadily Insurance Company
Published on 11/21/2024 at 14:00, 20 minutes ago Montara Raises $5.4M to Help Organizations Deliver Better Data Products Faster
Published on 11/21/2024 at 14:00, 20 minutes ago Tevir Capital LP Ltd. Updates Early Warning Reporting in Respect of VerticalScope Holdings Inc.
Published on 11/21/2024 at 13:30, 50 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 14:16, 4 minutes ago EQS-Adhoc: LM PAY S.A. Announces Third Quarter 2024 Preliminary Results and Updated Guidance
Published on 11/21/2024 at 14:15, 5 minutes ago ZenaTech Signs Blue UAS and NDAA Compliant Supply Chain Partners to Sell to US Defense Branches and NATO Forces
Published on 11/21/2024 at 12:35, 1 hour 45 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 06:58, 7 hours 22 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 19 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 35 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 35 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo